Clinical Lab Chat

In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).
 
The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:
  • Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.
  • The benefits of blood-based biomarkers for Alzheimer’s diagnosis.
  • How better diagnostics will benefit patients.
  • Why we’re on the cusp of a new golden age of neurology
  • How more biomarkers fuel not only better diagnostics but better treatments.

What is Clinical Lab Chat?

Step into the world of clinical labs with a podcast that delves deep into both the science and the strategy. From groundbreaking diagnostic and molecular testing to the intricacies of lab management, our episodes offer a comprehensive look at the ever-evolving lab landscape. We bring you the latest in lab technology, innovative testing procedures, and key insights from industry decision-makers and influencers. Beyond the science, we also focus on the operational side of things, offering tips and trends in lab management, ensuring your lab runs efficiently and stays ahead of the curve. Whether you're deep into the world of clinical diagnostics or looking to enhance your lab's operational excellence, this podcast provides the insights you need to stay at the pinnacle of lab advancements.